• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Optimal stroke prevention in patients with patent foramen ovale
Publication date: Available online 16 October 2018Source: The Lancet NeurologyAuthor(s): Bernhard Meier
Source: The Lancet Neurology - October 17, 2018 Category: Neurology Source Type: research

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
Publication date: Available online 28 September 2018Source: The Lancet NeurologyAuthor(s): Scott E Kasner, Balakumar Swaminathan, Pablo Lavados, Mukul Sharma, Keith Muir, Roland Veltkamp, Sebastian F Ameriso, Matthias Endres, Helmi Lutsep, Steven R Messé, J David Spence, Krassen Nedeltechev, Kanjana Perera, Gustavo Santo, Veronica Olavarria, Arne Lindgren, Shrikant Bangdiwala, Ashkan Shoamanesh, Scott D Berkowitz, Hardi MundlSummaryBackgroundPatent foramen ovale (PFO) is a contributor to embolic stroke of undetermined source (ESUS). Subgroup analyses from previous studies suggest that anticoagulation could reduce recurren...
Source: The Lancet Neurology - October 5, 2018 Category: Neurology Source Type: research

Epidemiology, aetiology, and management of ischaemic stroke in young adults
Publication date: September 2018Source: The Lancet Neurology, Volume 17, Issue 9Author(s): Merel S Ekker, Esther M Boot, Aneesh B Singhal, Kay Sin Tan, Stephanie Debette, Anil M Tuladhar, Frank-Erik de LeeuwSummaryEpidemiological evidence suggests that the incidence of ischaemic stroke in young adults (18–50 years) has increased substantially. These patients have a long life expectancy after stroke, and the costs of long-term care pose huge challenges to health-care systems. Although the current recommendations for treatment of young and old (>50 years) patients with stroke are similar, the optimal management of young ad...
Source: The Lancet Neurology - August 15, 2018 Category: Neurology Source Type: research

Patent foramen ovale in older patients with cryptogenic stroke or transient ischaemic attack
Publication date: July 2018Source: The Lancet Neurology, Volume 17, Issue 7Author(s): David Thaler
Source: The Lancet Neurology - July 10, 2018 Category: Neurology Source Type: research

Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis
Publication date: July 2018Source: The Lancet Neurology, Volume 17, Issue 7Author(s): Sara Mazzucco, Linxin Li, Lucy Binney, Peter M Rothwell, Oxford Vascular Study Phenotyped CohortSummaryBackgroundPercutaneous closure of patent foramen ovale (PFO) has been shown to be superior to medical treatment alone for prevention of recurrent stroke after cryptogenic transient ischaemic attack or non-disabling stroke in patients aged 60 years or younger. The justification for trials in older patients with transient ischaemic attack or stroke depends on whether PFO is shown to be associated with cryptogenic events at older ages, for ...
Source: The Lancet Neurology - July 10, 2018 Category: Neurology Source Type: research

Patent foramen ovale in older patients with cryptogenic stroke or transient ischaemic attack
Publication date: July 2018Source: The Lancet Neurology, Volume 17, Issue 7Author(s): David Thaler
Source: The Lancet Neurology - July 5, 2018 Category: Neurology Source Type: research

Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis
Publication date: Available online 7 June 2018 Source:The Lancet Neurology Author(s): Sara Mazzucco, Linxin Li, Lucy Binney, Peter M Rothwell Background Percutaneous closure of patent foramen ovale (PFO) has been shown to be superior to medical treatment alone for prevention of recurrent stroke after cryptogenic transient ischaemic attack or non-disabling stroke in patients aged 60 years or younger. The justification for trials in older patients with transient ischaemic attack or stroke depends on whether PFO is shown to be associated with cryptogenic events at older ages, for which existing evidence is conflicting, and o...
Source: The Lancet Neurology - June 8, 2018 Category: Neurology Source Type: research

Patent foramen ovale in older patients with cryptogenic stroke or transient ischaemic attack
Publication date: Available online 7 June 2018 Source:The Lancet Neurology Author(s): David Thaler
Source: The Lancet Neurology - June 8, 2018 Category: Neurology Source Type: research